An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors.
Multi-case radiotherapy series informs treatment decisions for ultra-rare bone tumour with virtually no existing clinical evidence.
Krcek et al. evaluated radiotherapy outcomes in a multi-case series of perivascular epithelioid cell tumour patients, reporting local control rates and toxicity profiles published in British Journal of Radiology. Given the extreme rarity and absence of randomised evidence, this series represents one of the larger single-institution datasets informing treatment decisions for this orphan mesenchymal neoplasm with high unmet therapeutic need.
What the study was
- Study design
- Retrospective multi-case evaluation
- Population
- PEComa patients treated with radiotherapy
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Br J Radiol
Why it surfaced
Treatment evidence for PEComa, an ultrarare mesenchymal tumour with high unmet need; British Journal of Radiology publication.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.